SCHEMBL29128686

SCHEMBL29128686

[CH2]C(=O)NC(=O)Nc1cc(C(F)(F)F)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.50
CLK2 P49760 3/20 0.50
CLK4 Q9HAZ1 3/20 0.50
STK17A Q9UEE5 3/20 0.50
IRAK1 P51617 2/20 0.50
NEK4 P51957 2/20 0.50
MAP4K2 Q12851 2/20 0.50
HIPK4 Q8NE63 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
SRPK1 Q96SB4 1/20 0.50
MAP3K20 Q9NYL2 1/20 0.50
MAP4K5 Q9Y4K4 1/20 0.50
RIOK2 Q9BVS4 1/20 0.49
IDH2 P48735 4/20 0.48
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
FBP1 P09467 1/20 0.46
NR3C2 P08235 2/20 0.45
AR P10275 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16637563 0.82 KDR (0.55) KDRCLK2CLK4STK17AIRAK1
SCHEMBL29128624 0.82 RIOK2 (0.52) KDRCLK2CLK4STK17AIRAK1
SCHEMBL2635853 0.80 ALDH1A1 (0.56) KDRCLK2CLK4STK17AIRAK1
SCHEMBL31264157 0.80 ALDH1A1 (0.56) KDRCLK2CLK4STK17AIRAK1
SCHEMBL9628989 0.79 GAA (0.48) KDRCLK2CLK4STK17AIRAK1
SCHEMBL3192275 0.78 L3MBTL1 (0.55) KDRCLK2CLK4STK17AIRAK1
SCHEMBL30875900 0.78 NR3C2 (0.67) KDRCLK2CLK4STK17AIRAK1
SCHEMBL5029590 0.78 NR3C2 (0.67) KDRCLK2CLK4STK17AIRAK1
SCHEMBL29128637 0.78 RAB9A (0.63) GAARPS6KA3KMT2AEPAS1
SCHEMBL25406525 0.76 KDR (0.71) KDRCLK2CLK4STK17AIRAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117263873-A 1, 4-benzodiazepine compounds and application thereof in preparation of antitumor drugs 复旦大学 2023-12-22 CN disclosed